PropertyValue
nif:beginIndex
  • 0 (xsd:integer)
nif:broaderContext
nif:endIndex
  • 151 (xsd:integer)
nif:isString
  • The effects and safety profile of ranibizumab and pegaptanib are less well studied, neither are the effects of bevacizumab on other VHL-related tumors.
rdf:type